http://www.healasthma.com
|
|
http://www.healasthma.com – . KNIGHT-RIDDER/TRIBUNE BUSINESS NEWS – BRITAIN APPROVES MIAMI’S IVAX TO SELL ASTHMA DEVICE, COMPANY SAYS FORT LAUDERDALE, Fla.–Jul. –Ivax Corp. said it won approval from regulators in the United Kingdom to sell a generic asthma drug in a device that is activated when the asthma patient inhales.The patented device is being rolled out after a half dozen years of research and development by Ivax’s U.K. subsidiary, Norton Helthcare. In , the first approval of the breath activated device was received for beclomethasone.The latest approval was for albuterol.Ivax spokesman… . Nuevo Herald, El (Miami, FL) – LOS ASM�TICOS PAGAR�N M�S POR LOS INHALADORES Dentro de poco, los pacientes de asma abonar�n m�s por los inhaladores de emergencia, que cada vez se vuelven m�s escasos, como parte del precio que tendr�n que pagar para proteger el ambiente.Seg�n el gobierno, para finales del los fabricantes de los vaporizadores de albuterol -que son utilizados por millones de personas para reabir los bronquios durante ataques de asma- tendr�n que dejar de usar los inhaladores de clorofluorocarb�n (CFC), que est�n destruyendo la capa de… Asthma plan helps to control condition KID CARE Q. My -year-old daughter has asthma. The school nurse sent home a form called an asthma action plan. When the form was completed at the doctor’s office, it listed medicines that my daughter was supposed to take at different times, but she only has the albuterol pump. She only needs the pump a couple of times a year. I called the doctor’s office and the nurse said one medication was a steroid, but my daughter hasn’t ever been on a steroid. We have an… . Straight From the Doc – Albuterol over Epinephrine in Infants with Bronchiolitis ( Straight From the Doc delivered by Newstex) — The most common cause of hospital admissions in infants is the condition called bronchiolitis – a wheezing very similar to asthma in adults.Generally used to treat this condition are two drugs epinephrine (a sympathomimetic agent) and albuterol (a bronchodilator). However, there is some controversy in choosing one over the other. Like in the treatment of most allergic reaction, epinephrine… . The Dallas Morning News – Medical recalls what to do Warnings about health-related devices aren’t always widespread The recall of potentially dangerous products has become a fact of life – but when it is drugs or medical devices that are on the list, you have to find out for yourself.Some recalls are widely publicized, such as the recall earlier this year of certain size vials of albuterol sulfate, a widely used asthma inhalant.The manufacturer took action after consultation with the Food and Drug Administration because bacterial contamination found in some vials posed the risk of serious… . GlobeNewswire (USA) – MediciNova Reports Interim Phase II Data From MN- Emergency Department Study, MediciNova Initiates Phase II Placebo-controlled Clinical Trial Evaluating MN- in Patients With Severe, Acute Exacerbations of Asthma MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number ), today announced interim results from two planned reviews of the unaudited data for its MN- -CL- Phase II study, which remains ongoing. These reviews included data from a total of (eight treated with standard care only and ten treated with MN- plus standard care) of planned patients with severe,… . GENES GUIDE ASTHMA DRUG’S EFFECTIVENESS, STUDY FINDS In a step toward an age of ”personalized medicines,” researchers have found gene variations that affect the way individual asthma sufferers respond to a drug widely used to control acute attacks.Out of thousands of variations in a single gene, researchers said they have identified that determine how well asthma patients respond to albuterol, the drug most commonly used to prevent or to control acute attacks.The study appears today… . SCIENTISTS ID ASTHMA GENES In a step toward an age of “personalized medicines,” researchers have found gene variations that affect the way individual asthma sufferers respond to a drug widely used to control acute attacks.Out of thousands of variations in a single gene, the researchers said they have identified that determine how well asthma patients respond to albuterol, a drug commonly used to prevent or to control acute attacks.The study findings appear today in the Proceedings of… . Chemical Business NewsBase Company Reports – CBNB (United Kingdom) – Chemical Business NewsBase – Company Reports – CBNB New and generic drug approvals Albuterol Sulfate Inhalation Solution, Lannett. [ table in original article] On Dec the US Food and Drug Administration announced approval of ANDA for Albuterol Sulfate Inhalation Solution. The product contains albuterol sulfate at . % (eq base), is manufactured by Lannett, and is prescription only. There are ten therapeutic equivalents (data in table). The label is not available on the website. … . Chemical Business NewsBase US Food and Drug Administration News (United Kingdom) – Chemical Business NewsBase – US Food and Drug Administration News New and generic drug approvals Albuterol Sulfate Inhalation Solution, Lannett. [ table in original article] On Dec the US Food and Drug Administration announced approval of ANDA for Albuterol Sulfate Inhalation Solution. The product contains albuterol sulfate at . % (eq base), is manufactured by Lannett, and is prescription only. There are ten therapeutic equivalents (data in table). The label is not available on the website. … – |
http://www.healasthma.com
|
{ 2009 08 11 }


